8:10AM Penwest Pharma beats by $0.01, beats on revs (PPCO) 2.29 : Reports Q3 (Sep) earnings of $0.01 per share, $0.01 better than the First Call consensus of ($0.00); revenues rose 350.0% year/year to $6.3 mln vs the $6.2 mln consensus.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.